Ang2 inhibitor (Medical Research Council Technology)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameAng2 inhibitor (Medical Research Council Technology)
Drug Alias Nameangiopoietin-2 inhibitor (Medical Research Council Technology)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiopoietin-2 inhibitors
TargetsAngiopoietin-2
Therapy Area/IndicationsInflammationNeoplasmsSepsis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLifearc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLifearc
Active IndicationsN/A
Inactive IndicationsInflammationNeoplasmsSepsis

Other Information

ATC CodeN/A
Related LinksN/A